"There is still work to be done to translate [user growth] into revenue growth,” Twitter tells shareholders.
The drugmaker says it incorrectly classified royalties from the best-selling Tysabri drug as an intangible asset rather than a financial asset.
Drugs such as the diabetes treatment Trulicity "led the company to a strong quarter of volume-driven revenue growth."
The retailer's current controller takes over as finance chief as it struggles to restructure through asset sales and store closures.
Industrial cash flow came in low, disappointing investors, but GE still expects to hit $12 billion to $14 billion for the year.
The company has been more aggressively marketing its products and making changes to the Platinum Card to recover from the loss of its Costco…
Investors express their impatience with the pace of IBM's turnaround effort by sending its shares down nearly 5% to $161.84.
Tepid growth in pharmaceuticals and consumer products held back first-quarter sales but the company is still confident it will meet its full-year…
The deal will expand Cardinal's medical products business but its shares dropped 11.5% on updated guidance for fiscal 2017.
“We underperformed this quarter,” new CFO R. Martin Chavez says as the firm reports its first earnings miss since the fourth quarter of 2015.